A one-pot, zinc gluconate crosslinked gellan gum formulation co-loaded with CAPE and punicalagin: in vitro and ex vivo activity against Candida albicans

Background Salivary washout, limited mucosal retention, and Candida albicans biofilms hinder topical treatment of oral candidiasis (OC). Incorporating caffeic acid phenethyl ester (CAPE) and punicalagin into gellan gum (GG) may improve antifungal efficacy.Objective To develop a one-pot, zinc gluconate-cross-linked GG formulation co-loaded with CAPE and punicalagin and evaluate its antifungal activity.Methods Physicochemical properties, release in artificial saliva, antifungal activity, cytotoxicity, haemolysis, simulated chewing, and ex vivo efficacy on porcine buccal tissue were assessed.Results The cumulative release was 284.9 μg (CAPE-GG) and 756.3 μg (punicalagin-GG) versus 247.2 μg CAPE and 370.1 μg punicalagin from CAPE+punicalagin-GG in 24 h. CAPE+punicalagin-GG reduced the C. albicans burden to 103 CFU/mL under shaking and maintained activity for 72 h under static conditions (P < 0.0001). It reduced biofilm viability to 20% (P < 0.0001), compared with fluconazole-GG (49–66%) and untreated control (100%) in 24 and 48 h biofilms. It also inhibited hyphal formation (P < 0.0001), maintained 56% HGF-1 viability, and exhibited low haemolysis (P < 0.0001). GG formulations retained antifungal activity under simulated chewing. CAPE+punicalagin-GG reduced early fungal porcine buccal tissue colonisation by 1.7 log10 CFU (P = 0.0057) relative to the untreated control.Conclusions CAPE+punicalagin-GG demonstrated antibiofilm, antihyphal activity and reduced ex vivo fungal colonization. These study support the GG formulation's translational potential against C. albicans.

Authors

Institutions

Publication Details

Journal
Journal of Oral Microbiology
Published
2026-11-12
DOI
https://doi.org/10.1080/20002297.2026.2737713
Primary Topic
Antifungal resistance and susceptibility
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

A one-pot, zinc gluconate crosslinked gellan gum formulation co-loaded with CAPE and punicalagin: in vitro and ex vivo activity against Candida albicans

Narchonai Ganesan, Eleftherios E Mylonakis, Alessandro Grattoni, Yongbin Liu et al.
Journal of Oral Microbiology
Antifungal resistance and susceptibility
article

A one-pot, zinc gluconate crosslinked gellan gum formulation co-loaded with CAPE and punicalagin: in vitro and ex vivo activity against Candida albicans

Narchonai Ganesan, Eleftherios E Mylonakis, Alessandro Grattoni, Yongbin Liu, Thi‐Thao‐Linh Nguyen, Roger Mauricio Arce, Danielle Wu, Fadi Shehadeh, Liyang Zhang, Biswajit Mishra, Lewis Oscar Felix
article en

Abstract

Background Salivary washout, limited mucosal retention, and Candida albicans biofilms hinder topical treatment of oral candidiasis (OC). Incorporating caffeic acid phenethyl ester (CAPE) and punicalagin into gellan gum (GG) may improve antifungal efficacy.Objective To develop a one-pot, zinc gluconate-cross-linked GG formulation co-loaded with CAPE and punicalagin and evaluate its antifungal activity.Methods Physicochemical properties, release in artificial saliva, antifungal activity, cytotoxicity, haemolysis, simulated chewing, and ex vivo efficacy on porcine buccal tissue were assessed.Results The cumulative release was 284.9 μg (CAPE-GG) and 756.3 μg (punicalagin-GG) versus 247.2 μg CAPE and 370.1 μg punicalagin from CAPE+punicalagin-GG in 24 h. CAPE+punicalagin-GG reduced the C. albicans burden to 103 CFU/mL under shaking and maintained activity for 72 h under static conditions (P < 0.0001). It reduced biofilm viability to 20% (P < 0.0001), compared with fluconazole-GG (49–66%) and untreated control (100%) in 24 and 48 h biofilms. It also inhibited hyphal formation (P < 0.0001), maintained 56% HGF-1 viability, and exhibited low haemolysis (P < 0.0001). GG formulations retained antifungal activity under simulated chewing. CAPE+punicalagin-GG reduced early fungal porcine buccal tissue colonisation by 1.7 log10 CFU (P = 0.0057) relative to the untreated control.Conclusions CAPE+punicalagin-GG demonstrated antibiofilm, antihyphal activity and reduced ex vivo fungal colonization. These study support the GG formulation's translational potential against C. albicans.

Journal of Oral MicrobiologyVol. 18(1)
Houston Methodist (US), National Technical University of Athens (GR), Houston Methodist Research Institute (US), Rice University (US), The University of Texas Health Science Center at Houston (US)
National Institutes of Health
Good health and well-being
Antifungal resistance and susceptibility
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon